Oruka Therapeutics

ORKANasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$6.358 B

$96.03 -5.31%

Close of 6 Nov 2026

As of 6 Nov 2026, Oruka Therapeutics (ORKA) has a market capitalization of $6.36B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$105.4M

Loss-making

Shares outstanding

66,209,699

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#1Idexx LaboratoriesIDXX$52.9B
#2LantheusLNTH$6.58B
#3Oruka TherapeuticsORKA$6.36B
#4NeogenNEOG$2.54B
#5Celldex TherapeuticsCLDX$2.22B

What if Oruka Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$426,476.40

Per share 4,441× higher

Bitcoin $1.53T

$23,075.90

Per share 240× higher

Apple $5.02T

$75,756.01

Per share 789× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Oruka Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.